SiO2 Materials Science

SiO2 Materials Science is a primary packaging company rooted in research and development. It invented a first-of-its-kind vyterial™ coating technology that gives primary packaging the barrier properties of glass, the durability of plastic, and is made of sustainable materials. The technology is protected by more than 300 patents and close to 8000 patent claims. The company relies on state-of-the-art facilities in Auburn, Alabama, providing vertically integrated and digitally enabled manufacturing. Its products include syringes, vials, blood tubes, and custom applications.

SiO2 was founded in 2012 to develop and produce a proprietary container technology which fuses the benefits of glass and plastic, without the key drawbacks of either, to address major unmet needs for container systems in the molecular diagnostics and pharmaceuticals industries. In 2021, SiO2 commercialized a blood collection tube with a proprietary preservative to address the genetic testing market. Over the past ten years, SiO2 has worked collaboratively with customers to design, produce, and commercialize vials and syringes specifically for biologic drug formulations, including bioengineered vaccines (mRNA), antibody drug conjugates (ADC), and cell and gene therapies (CGT).

A new standard of primary packaging combining the best of glass and polymers without the drawbacks of either.

• Syringes

• Vials

• Blood tubes

• Custom applications

• Unconfirmed

  SiO2 Materials Science increases vaccine-vial production[5]SiO2 Materials Science增加疫苗瓶产量wtvm.com

  Reported: 2021-01-26

  SiO2 Materials Science increased production from about 10 million vials per year to 10 million per month and reported operating four manufacturing sites instead of one. It said it had shipped vials to Moderna and other companies developing COVID-19 vaccines.

1. 1Home - SiO2sio2ms.com
2. 2History - SiO2sio2ms.com
3. 3Company - SiO2sio2ms.com
4. 4Products - SiO2sio2ms.com
5. 5SiO2 Materials Science增加疫苗瓶产量wtvm.com